Sustainable chemistry bill passes Senate chemweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chemweek.com Daily Mail and Mail on Sunday newspapers.
ESCAPE Bio Appoints Edward Owens and Scott Morrison to Board of Directors SOUTH SAN FRANCISCO, Calif. (Business Wire) ESCAPE Bio Inc., a clinical stage company developing novel, precisely targeted therapeutics for genetic neurodegenerative diseases, announced that Edward Owens and Scott Morrison have been appointed to the Board of Directors.
“Ed brings an unparalleled perspective of our industry based on over four decades of outstanding performance investing in healthcare companies,” said Julie Anne Smith, CEO. “We are delighted to have his insight on business fundamentals, industry insights and shareholder value.”
“Scott is a well-respected industry leader who brings over 40 years of financial experience helping life science companies grow from start-up, through initial product launch, to global expansion,” said Tony Rimac, CFO. “We look forward to his financial acumen and corporate insight as we advance our pipeline of Precision Neurology medicines.”
Selected Researchers and Startups Win Hearts, Minds and $$ at Pacific NW Life Science Event - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
Oncologists sue to stop White House outpatient drug pay rule
Modern Healthcare Illustration / Getty Images
Community oncologists are suing the Trump administration to stop implementation of its new outpatient drug pay demonstration, which would cut Medicare reimbursement for certain high-spend drugs.
The Community Oncology Alliance argues that CMS plan to tie drug payment to foreign prices in Medicare Part B would cause financial hardship for providers, reduce patient access, and reduce pay rates from other payers. The model depends on providers negotiating drugmakers prices down to meet reduced reimbursement levels. Defendants wrongful acts compromise access to cancer care for seniors who will not be able to be treated by their oncologists, with a significant number of seniors having to forgo treatment altogether, or being unable to find or afford treatment when their local community oncology practice is forced to absorb losses causing the practice to shut down or join a mor